Lv3
340 积分 2022-11-15 加入
A systematic review on second treatment-free remission (TFR) attempt in chronic myeloid leukemia (CML): Can it be applied in clinical practice?
7个月前
已完结
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial
7个月前
已完结
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors
7个月前
已完结
Chronic myeloid leukaemia: Biology and therapy
7个月前
已完结
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients
7个月前
已完结
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha
7个月前
已完结
Failure of treatment-free remission after a prolonged deep molecular response in patients with chronic myeloid leukemia
7个月前
已完结
How to improve treatment‐free remission eligibility in chronic myeloid leukaemia?
8个月前
已完结
Challenges and strategies associated with CAR-T cell therapy in blood malignancies
9个月前
已完结
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
9个月前
已完结
The intracellular Ca 2+ channel TRPML3 is a PI3P effector that regulates autophagosome biogenesis
皖公网安备34019202002308
